MENU
+Compare
XOMAP
Stock ticker: NASDAQ
AS OF
Sep 3, 12:05 PM (EDT)
Price
$26.65
Change
+$0.80 (+3.09%)

XOMAP XOMA Corp Forecast, Technical & Fundamental Analysis

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health... Show more

XOMAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for XOMAP with price predictions
Sep 02, 2025

XOMAP's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for XOMAP turned positive on August 20, 2025. Looking at past instances where XOMAP's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 20, 2025. You may want to consider a long position or call options on XOMAP as a result. In of 121 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XOMAP advanced for three days, in of 200 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for XOMAP moved out of overbought territory on August 28, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 66 cases where XOMAP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XOMAP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

XOMAP broke above its upper Bollinger Band on August 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for XOMAP entered a downward trend on August 19, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (19.877). P/E Ratio (0.000) is within average values for comparable stocks, (52.033). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.227). Dividend Yield (0.083) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (323.422).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XOMAP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XOMAP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
XOMAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

XOMAP paid dividends on July 15, 2025

XOMA Corp XOMAP Stock Dividends
А dividend of $0.54 per share was paid with a record date of July 15, 2025, and an ex-dividend date of July 03, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2200 Powell Street
Phone
+1 510 204-7200
Employees
13
Web
https://www.xoma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
W77.653.05
+4.09%
Wayfair
MSBI18.470.05
+0.27%
Midland States Bancorp
CHCO127.93-0.55
-0.43%
City Holding Company
BANFP26.00-0.15
-0.57%
BancFirst Corp
HOVR1.69-0.06
-3.43%
New Horizon Aircraft Ltd

XOMAP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMAP has been loosely correlated with AMLX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if XOMAP jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMAP
1D Price
Change %
XOMAP100%
-1.34%
AMLX - XOMAP
51%
Loosely correlated
+6.40%
CGEN - XOMAP
31%
Poorly correlated
+1.42%
RNAC - XOMAP
29%
Poorly correlated
-2.09%
XOMAO - XOMAP
27%
Poorly correlated
+0.03%
MGTX - XOMAP
26%
Poorly correlated
N/A
More